35. Efficacy and Safety of Valsartan Monotherapy or in Single-Pill Combination Compared to Other Anti-Hypertension Drugs: A Systematic Review

ST Lim, E Huang, A Kurniawan - Journal of Hypertension, 2024 - journals.lww.com
Background: Valsartan is one of the drugs that can be used as a first-line treatment for mild
to moderate hypertension. It reduces blood pressure by inhibiting angiotensin II from …

Efficacy and safety of valsartan compared with enalapril at different altitudes

R Botero, H Matiz, E Marıa, H Orejarena… - International journal of …, 2000 - Elsevier
Objective: To compare the safety, tolerability, and antihypertensive efficacy of valsartan with
enalapril at different altitudes. Method: A total of 142 adult Colombian outpatients with mild …

[引用][C] Introduction of valsartan into the'Preferred Prescribing Practice'list for Wokingham PCT

M YASSAIE - British journal of cardiology, 2003 - MediNews

The hypotensive effect and tolerance of valsartan (Diovan) in hypertension in a general clinical practice

AI Ivleva, MA Sokolova… - Terapevticheskii …, 1999 - pubmed.ncbi.nlm.nih.gov
Aim An assessment of a hypotensive effect and tolerance of valsartan. Materials and
methods In 20 patients with mild and moderate blood hypertension (BH) the latter was …

Long term safety and efficacy of valsartan

J Hall, T Marbury, A Hester, H Zheng… - American Journal of …, 1998 - elibrary.ru
Angiotensin II antagonists represent a new class of effective and well tolerated
antihypertensive agents. To date many studies with these agents have been of short …

Valsartan alone and in combination with hydrochlorothiazide in general practice: results from two postmarketing surveillance studies involving 54 928 patients with …

J Scholze, G Probst, K Bertsch - Clinical Drug Investigation, 2000 - Springer
Objectives: To assess the efficacy and tolerability of valsartan and valsartan plus
hydrochlorothiazide (HCTZ), given alone or as part of a combination regimen with other …

[引用][C] Patients of Southern Asian descent treated with valsartan (POSATIV) study

JKV PATEL, R LEABACK - British journal of cardiology, 2002 - MediNews

Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or both

P Verdecchia, F Angeli - Clinical therapeutics, 2004 - Elsevier
Background: Recent data suggest that use of relatively high doses of angiotensin II-receptor
blockers (ARBs) in hypertensive patients at high cardiovascular risk may reduce the …

Antihypertensive effects of valsartan. National multicentric study

H Prat - Revista Medica de Chile, 2000 - europepmc.org
[Antihypertensive effects of valsartan. National multicentric study]. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

34. Efficacy and Safety of Sacubitril Valsartan in Managing Hypertension Compared with Angiotensin Receptor Blockers: A Systematic Review and Meta-analysis

D Sukmadja, AS Prawara, KC Prasiddha… - Journal of …, 2023 - journals.lww.com
Background: Sacubitril/Valsartan has shown promising result in the management of heart
failure with reduced ejection fraction patients. However, it also withhold the potential as …